222110 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
PanGen Biotech, Inc. engages in the production and sales of biopharmaceuticals. Its products include biosimilar erythropoietin (EPO), recombinant Factor VIII, biosimilar Aflibercept, recombinant anti-SFTSV Ab, and biosimilar G-CSF. The company was founded on January 29, 2010 and is headquartered in Suwon-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
222110 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company